|
KR102643923B1
(ko)
|
2014-12-23 |
2024-03-05 |
이매틱스 바이오테크놀로지스 게엠베하 |
간세포 암종(hcc) 및 기타 암들에 대한 면역요법에서의 사용을 위한 신규 펩티드 및 펩티드의 조합
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
US9422547B1
(en)
|
2015-06-09 |
2016-08-23 |
Gigagen, Inc. |
Recombinant fusion proteins and libraries from immune cell repertoires
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
JP2020521452A
(ja)
|
2017-05-24 |
2020-07-27 |
パンディオン・セラピューティクス・インコーポレイテッド |
標的化免疫寛容
|
|
US10946068B2
(en)
|
2017-12-06 |
2021-03-16 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10174091B1
(en)
|
2017-12-06 |
2019-01-08 |
Pandion Therapeutics, Inc. |
IL-2 muteins
|
|
US20210061914A1
(en)
*
|
2017-12-28 |
2021-03-04 |
Gritstone Oncology, Inc. |
Antigen-Binding Proteins Targeting Shared Antigens
|
|
CN112236447B
(zh)
*
|
2018-04-19 |
2023-10-20 |
得克萨斯州大学系统董事会 |
具有mage-b2特异性的t细胞受体及其用途
|
|
IL280890B2
(en)
*
|
2018-08-17 |
2025-10-01 |
Gritstone Bio Inc |
Antigen-binding protein that targets shared antigens
|
|
CN111138521B
(zh)
*
|
2018-11-06 |
2022-10-28 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
CN111138522B
(zh)
*
|
2018-11-06 |
2023-01-24 |
香雪生命科学技术（广东）有限公司 |
衍生自afp的肿瘤抗原短肽
|
|
WO2020172332A1
(en)
*
|
2019-02-20 |
2020-08-27 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for ras neoantigens and uses thereof
|
|
WO2020191365A1
(en)
|
2019-03-21 |
2020-09-24 |
Gigamune, Inc. |
Engineered cells expressing anti-viral t cell receptors and methods of use thereof
|
|
EP3714941A1
(en)
*
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
US20200318068A1
(en)
*
|
2019-04-04 |
2020-10-08 |
Immatics US, Inc. |
Use of retinoic acid in t-cell manufacturing
|
|
SG11202110956RA
(en)
|
2019-04-05 |
2021-10-28 |
Rootpath Genomics Inc |
Compositions and methods for t-cell receptor gene assembly
|
|
EP3962939A4
(en)
*
|
2019-05-03 |
2023-05-17 |
Gigamune, Inc. |
MODIFIED CELLS EXPRESSING ANTITUMOR T-LYMPHOCYTE RECEPTORS AND METHODS OF USING THEM
|
|
KR20220030933A
(ko)
|
2019-05-08 |
2022-03-11 |
메디진 이뮤노테라피스 게엠바하 |
조작된 t 세포
|
|
WO2020236875A1
(en)
|
2019-05-20 |
2020-11-26 |
Pandion Therapeutics, Inc. |
Madcam targeted immunotolerance
|
|
EP3760217A1
(en)
*
|
2019-07-01 |
2021-01-06 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Cd5 specific t cell receptor cell or gene therapy
|
|
WO2021005108A1
(en)
*
|
2019-07-09 |
2021-01-14 |
Medigene Immunotherapies Gmbh |
Magea10 specific t cell receptors and their use
|
|
CN114761041A
(zh)
|
2019-07-16 |
2022-07-15 |
吉利德科学公司 |
Hiv疫苗及其制备和使用方法
|
|
CN112300261B
(zh)
*
|
2019-07-23 |
2023-03-17 |
香雪生命科学技术（广东）有限公司 |
一种衍生自afp的肿瘤抗原短肽
|
|
TW202124437A
(zh)
*
|
2019-08-19 |
2021-07-01 |
美商潘迪恩營運公司 |
以ｐｄ－１促效劑進行之標靶免疫耐受性
|
|
WO2021048381A1
(en)
*
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying stable mhc binding peptides using mass spectrometry
|
|
US20220372092A1
(en)
*
|
2019-10-18 |
2022-11-24 |
Board Of Regents, The University Of Texas System |
Hla-restricted vcx/y peptides and t cell receptors and use thereof
|
|
WO2021092094A1
(en)
*
|
2019-11-04 |
2021-05-14 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared neoantigens
|
|
AU2020384374A1
(en)
*
|
2019-11-15 |
2022-06-09 |
Seattle Project Corp. |
Antigen-binding proteins targeting shared neoantigens
|
|
CN112898399A
(zh)
*
|
2019-12-03 |
2021-06-04 |
香雪生命科学技术（广东）有限公司 |
源自于afp抗原的短肽
|
|
CN115785254A
(zh)
*
|
2019-12-13 |
2023-03-14 |
南京大户生物科技有限公司 |
原发性肝癌相关抗原的胸腺依赖性淋巴细胞抗原表位肽及其应用
|
|
CN113072636B
(zh)
*
|
2020-01-06 |
2024-05-28 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体及其编码序列
|
|
US11981715B2
(en)
|
2020-02-21 |
2024-05-14 |
Pandion Operations, Inc. |
Tissue targeted immunotolerance with a CD39 effector
|
|
CN113321727B
(zh)
*
|
2020-02-28 |
2024-04-09 |
香雪生命科学技术（广东）有限公司 |
一种识别afp抗原短肽的t细胞受体及其编码序列
|
|
CN113321725B
(zh)
*
|
2020-02-28 |
2024-06-11 |
香雪生命科学技术（广东）有限公司 |
一种识别afp的t细胞受体
|
|
KR20240096884A
(ko)
*
|
2020-03-10 |
2024-06-26 |
매사추세츠 인스티튜트 오브 테크놀로지 |
조작된 기억-유사 nk 세포 및 이의 조성물을 생성하기 위한 방법
|
|
US11896619B2
(en)
*
|
2020-03-10 |
2024-02-13 |
Massachusetts Institute Of Technology |
Compositions and methods for immunotherapy of NPM1c-positive cancer
|
|
CN113493505A
(zh)
*
|
2020-03-20 |
2021-10-12 |
香雪生命科学技术（广东）有限公司 |
识别afp抗原的高亲和力tcr
|
|
CN113621070A
(zh)
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
WO2021236548A1
(en)
*
|
2020-05-18 |
2021-11-25 |
Board Of Regents, The University Of Texas System |
Engineered t cell receptors and methods of use
|
|
US12312412B2
(en)
|
2020-05-19 |
2025-05-27 |
Amgen Inc. |
MAGEB2 binding constructs
|
|
CN116096740A
(zh)
*
|
2020-06-09 |
2023-05-09 |
得克萨斯州大学系统董事会 |
经改造t细胞受体和使用方法
|
|
JP7391208B2
(ja)
|
2020-07-08 |
2023-12-04 |
エルジー エナジー ソリューション リミテッド |
バッテリーパック及びそれを含む自動車
|
|
EP4188962A4
(en)
*
|
2020-07-29 |
2025-01-01 |
Gritstone bio, Inc. |
MANIPULATED MULTI-SPECIFIC ANTIBODIES AND RELATED METHODS OF USE AND PRODUCTION
|
|
EP4208473A2
(en)
*
|
2020-09-04 |
2023-07-12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
T cell receptors recognizing r273c or y220c mutations in p53
|
|
WO2022063966A1
(en)
*
|
2020-09-24 |
2022-03-31 |
Medigene Immunotherapies Gmbh |
Prame specific t-cell receptors and uses thereof
|
|
CN116615446A
(zh)
*
|
2020-09-24 |
2023-08-18 |
基因医疗免疫疗法有限责任公司 |
Mage-a3特异性t细胞受体及其用途
|
|
WO2022087380A1
(en)
*
|
2020-10-23 |
2022-04-28 |
Rootpath Genomics, Inc. |
Compositions and methods for t-cell receptor identification
|
|
JP2023548556A
(ja)
*
|
2020-11-05 |
2023-11-17 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
Ｅｇｆｒ抗原を標的とする操作されたｔ細胞受容体および使用方法
|
|
EP4277652A1
(en)
|
2021-01-14 |
2023-11-22 |
Gilead Sciences, Inc. |
Hiv vaccines and methods of using
|
|
EP4277925A4
(en)
*
|
2021-01-14 |
2025-06-11 |
Gritstone bio, Inc. |
Multispecific antibodies and methods of use
|
|
EP4294831A1
(en)
*
|
2021-02-16 |
2023-12-27 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hla class i-restricted t cell receptors against cd22
|
|
US11912771B2
(en)
|
2021-03-09 |
2024-02-27 |
Cdr-Life Ag |
MAGE-A4 peptide-MHC antigen binding proteins
|
|
EP4304725A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Rabbit-derived antigen binding protein nucleic acid libraries
|
|
US20240293459A1
(en)
*
|
2021-03-29 |
2024-09-05 |
Board Of Regents, The University Of Texas System |
Peptides and engineered t cell receptors targeting sars-cov-2 antigens and methods of use
|
|
EP4320144A4
(en)
*
|
2021-04-05 |
2025-04-09 |
Janssen Biotech, Inc. |
T CELL RECEPTORS CALR AND JAK2
|
|
CA3216276A1
(en)
|
2021-04-29 |
2022-11-03 |
Yardena Samuels |
T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying same
|
|
EP4091627A1
(en)
*
|
2021-05-21 |
2022-11-23 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Tcr constructs specific for magea4-derived epitopes
|
|
EP4347639A4
(en)
*
|
2021-05-25 |
2025-08-06 |
Memorial Sloan Kettering Cancer Center |
T CELL RECEPTORS TARGETING RAS MUTATIONS AND THEIR USES
|
|
CA3227687A1
(en)
*
|
2021-08-06 |
2023-02-09 |
Marc Andrew GILLIG |
Process for producing personalized cancer immunotherapy
|
|
WO2023050063A1
(zh)
*
|
2021-09-28 |
2023-04-06 |
溧阳瑅赛生物医药有限公司 |
一种识别hla-a*02:01/e629-38的tcr及其应用
|
|
CA3236237A1
(en)
*
|
2021-10-25 |
2023-05-04 |
Board Of Regents, The University Of Texas System |
Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use
|
|
EP4423143A4
(en)
*
|
2021-10-29 |
2025-10-01 |
Yafei Hou |
T CELL RECEPTOR RECOGNIZING R175H MUTATION IN P53 AND ITS APPLICATION
|
|
WO2023148494A1
(en)
*
|
2022-02-03 |
2023-08-10 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
CA3244259A1
(en)
*
|
2022-02-23 |
2023-08-31 |
Aloe Therapeutics Inc |
Compositions and methods for modulating the immune system
|
|
NL2031118B1
(en)
*
|
2022-03-01 |
2023-09-07 |
Academisch Ziekenhuis Leiden |
T cell receptors directed against transcription factor wt1 and uses thereof
|
|
CN116836261A
(zh)
*
|
2022-03-24 |
2023-10-03 |
香雪生命科学技术（广东）有限公司 |
一种识别mage-a4抗原的高亲和力tcr及其序列和应用
|
|
CN117264043B
(zh)
*
|
2022-06-14 |
2024-05-10 |
上海镔铁生物科技有限责任公司 |
靶向kras g12v突变多肽的t细胞受体及其用途
|
|
KR20250067130A
(ko)
|
2022-09-14 |
2025-05-14 |
씨디알-라이프 아게 |
Mage-a4 펩티드 이중 t 세포 연결체
|
|
EP4598569A1
(en)
*
|
2022-10-05 |
2025-08-13 |
Tscan Therapeutics, Inc. |
Magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof
|
|
CN116158405B
(zh)
*
|
2023-01-30 |
2024-04-26 |
西北农林科技大学 |
一种提高奶山羊后代母羔率的方法
|
|
WO2025064738A1
(en)
*
|
2023-09-22 |
2025-03-27 |
Regeneron Pharmaceuticals, Inc. |
Dntt 250-258 off-target peptides and uses thereof
|
|
WO2025093596A2
(en)
*
|
2023-10-30 |
2025-05-08 |
T-Knife Gmbh |
Antigen recognizing construct capable of binding to a preferentially expressed antigen in melanoma (prame) peptide and a t cell receptor (tcr) having antigenic specificity for prame as well as corresponding nucleic acid sequence, vector, host cell, pharmaceutical composition and kit
|
|
CN118256604B
(zh)
*
|
2024-04-16 |
2024-11-19 |
华中科技大学 |
一种利用人工抗原呈递细胞进行免疫原性肿瘤新抗原筛选与鉴定方法
|